drugset / Trial / NCT04509336
Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Muscle cramps are commonly affects patients with cirrhosis. It adversely influences the quality of life of cirrhotic patients. Treatment of muscle cramps still challenging owing to the diversity of the responsible pathophysiological mechanisms.The effectiveness of baclofen and orphenadrine in controlling muscle cramps in cirrhotic patients has been presented in recent randomised controlled clinical trials;however, the comparative efficacy and safety between these two therapeutic options has not been previously investigated.
Timeline
- Start
- 2020-08-20
- Primary completion
- 2020-12-01
- Completion
- 2021-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Baclofen | Small molecule | 10 mg | — |
| Subject | Orphenadrine | Small molecule | 100 mg | — |